Skip to main content
$3.85 $0.06 (1.5%)

11:55 AM EDT on 10/27/21

Antigenics, Inc. (NASDAQ:AGEN)

CAPS Rating: 1 out of 5

A biotechnology company, developing technologies and products to treat cancers and infectious diseases, based on immunological approaches.

Current Price $3.85 Mkt Cap $883.5M
Open $3.83 P/E Ratio 0.00
Prev. Close $3.79 Div. (Yield) $0.00 (0.0%)
Daily Range $3.75 - $3.86 Volume 1,195,556
52-Wk Range $2.50 - $6.79 Avg. Daily Vol. 4,269,718

Caps

How do you think NASDAQ:AGEN will perform against the market?

Add Stock to CAPS Watchlist

All Players

198 Outperform
89 Underperform
 

All-Star Players

23 Outperform
24 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:AGEN Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

zzlangerhans (99.01)
Submitted April 03, 2013

I'm an Agenus skeptic but I think there's a good chance of a rebound ahead of topline data from the phase II trial of HerpV therapeutic herpes simplex 2 vaccine expected in Q4 2013. A good bellwether for the trial results will be if Agenus decides to… More

Ernbo6 (22.78)
Submitted May 15, 2007

Antigenics Inc. is a biotechnology company developing technologies and products to treat cancers, infectious diseases and autoimmune disorders, primarily based on immunological approaches. Its advanced product candidate is Oncophage (vitespen,… More

NASDAQ:AGEN VS S&P 500 (SPY)

Fools bullish on NASDAQ:AGEN are also bullish on:

Fools bearish on NASDAQ:AGEN are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about AGEN.

Recs

0
Member Avatar StevesStox (< 20) Submitted: 7/15/2021 6:01:16 AM : Outperform Start Price: $5.46 NASDAQ:AGEN Score: -35.10

AGEN-1181 is the real deal.

Recs

0
Member Avatar PM7 (< 20) Submitted: 1/24/2021 12:14:01 AM : Outperform Start Price: $3.47 NASDAQ:AGEN Score: -8.96

Significant number of drugs under final stages of phase 2 and 3 trials and 2 of them likely to get FDA approval and both on FDA fast track.

Recs

0
Member Avatar rocknrook (58.77) Submitted: 6/27/2017 7:53:50 AM : Outperform Start Price: $4.01 NASDAQ:AGEN Score: -92.63

Assuming effective test results. I like that there is significant interest from big players in partnering.

Leaderboard

Find the members with the highest scoring picks in AGEN.

Score Leader

svande8952

svande8952 (87.89) Score: +466.09

The Score Leader is the player with the highest score across all their picks in AGEN.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
svande8952 87.89 6/16/2009 Underperform 5Y $12.24 -68.87% +397.22% +466.09 1 Comment
1or5stars 99.26 6/8/2009 Underperform 3W $13.68 -72.15% +391.04% +463.19 0 Comment
TWreckz 99.23 6/5/2009 Underperform 5Y $15.90 -76.04% +382.43% +458.47 0 Comment
rcbaldwinjr 78.73 8/5/2009 Underperform 3W $13.85 -72.50% +359.43% +431.93 0 Comment
rhinomaj < 20 8/4/2009 Underperform 3M $14.34 -73.43% +356.54% +429.97 0 Comment
epc53 26.33 8/7/2009 Underperform 5Y $13.26 -71.27% +353.95% +425.22 0 Comment
BadCopNoDonuts < 20 7/28/2010 Underperform 5Y $5.64 -32.45% +309.67% +342.11 0 Comment
JackOffBadApples 65.30 9/12/2008 Underperform 3W $10.02 -61.98% +278.51% +340.48 0 Comment
chop3399 < 20 3/13/2008 Underperform 5Y $13.44 -71.65% +266.70% +338.36 0 Comment
DayTr8der88 < 20 9/22/2008 Underperform NS $9.90 -61.52% +275.54% +337.05 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for AGEN.